February 20, 2026 · Form 4 insider transaction
Grimaud Brett A. sold 20,833 shares of Theravance Biopharma, Inc. at $19.66 per share, a transaction worth $409.6K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.